IBDEI06O ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2799,1,3,0)
 ;;=3^Keloid,Acne
 ;;^UTILITY(U,$J,358.3,2799,1,4,0)
 ;;=4^L73.0
 ;;^UTILITY(U,$J,358.3,2799,2)
 ;;=^2149
 ;;^UTILITY(U,$J,358.3,2800,0)
 ;;=L85.2^^18^208^50
 ;;^UTILITY(U,$J,358.3,2800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2800,1,3,0)
 ;;=3^Keratosis Punctata
 ;;^UTILITY(U,$J,358.3,2800,1,4,0)
 ;;=4^L85.2
 ;;^UTILITY(U,$J,358.3,2800,2)
 ;;=^5009322
 ;;^UTILITY(U,$J,358.3,2801,0)
 ;;=L85.1^^18^208^51
 ;;^UTILITY(U,$J,358.3,2801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2801,1,3,0)
 ;;=3^Keratosis,Acquired
 ;;^UTILITY(U,$J,358.3,2801,1,4,0)
 ;;=4^L85.1
 ;;^UTILITY(U,$J,358.3,2801,2)
 ;;=^5009321
 ;;^UTILITY(U,$J,358.3,2802,0)
 ;;=L43.9^^18^208^52
 ;;^UTILITY(U,$J,358.3,2802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2802,1,3,0)
 ;;=3^Lichen Planus,Unspec
 ;;^UTILITY(U,$J,358.3,2802,1,4,0)
 ;;=4^L43.9
 ;;^UTILITY(U,$J,358.3,2802,2)
 ;;=^5009183
 ;;^UTILITY(U,$J,358.3,2803,0)
 ;;=L28.0^^18^208^53
 ;;^UTILITY(U,$J,358.3,2803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2803,1,3,0)
 ;;=3^Lichen Simplex Chronicus
 ;;^UTILITY(U,$J,358.3,2803,1,4,0)
 ;;=4^L28.0
 ;;^UTILITY(U,$J,358.3,2803,2)
 ;;=^259859
 ;;^UTILITY(U,$J,358.3,2804,0)
 ;;=L93.0^^18^208^54
 ;;^UTILITY(U,$J,358.3,2804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2804,1,3,0)
 ;;=3^Lupus Erythematosus,Discoid
 ;;^UTILITY(U,$J,358.3,2804,1,4,0)
 ;;=4^L93.0
 ;;^UTILITY(U,$J,358.3,2804,2)
 ;;=^5009467
 ;;^UTILITY(U,$J,358.3,2805,0)
 ;;=L93.1^^18^208^56
 ;;^UTILITY(U,$J,358.3,2805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2805,1,3,0)
 ;;=3^Lupus Erythematosus,Subacute Cutaneous
 ;;^UTILITY(U,$J,358.3,2805,1,4,0)
 ;;=4^L93.1
 ;;^UTILITY(U,$J,358.3,2805,2)
 ;;=^5009468
 ;;^UTILITY(U,$J,358.3,2806,0)
 ;;=L93.2^^18^208^55
 ;;^UTILITY(U,$J,358.3,2806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2806,1,3,0)
 ;;=3^Lupus Erythematosus,Other
 ;;^UTILITY(U,$J,358.3,2806,1,4,0)
 ;;=4^L93.2
 ;;^UTILITY(U,$J,358.3,2806,2)
 ;;=^5009469
 ;;^UTILITY(U,$J,358.3,2807,0)
 ;;=L04.9^^18^208^60
 ;;^UTILITY(U,$J,358.3,2807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2807,1,3,0)
 ;;=3^Lymphadenitis,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,2807,1,4,0)
 ;;=4^L04.9
 ;;^UTILITY(U,$J,358.3,2807,2)
 ;;=^5009074
 ;;^UTILITY(U,$J,358.3,2808,0)
 ;;=R59.1^^18^208^57
 ;;^UTILITY(U,$J,358.3,2808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2808,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Generalized
 ;;^UTILITY(U,$J,358.3,2808,1,4,0)
 ;;=4^R59.1
 ;;^UTILITY(U,$J,358.3,2808,2)
 ;;=^5019530
 ;;^UTILITY(U,$J,358.3,2809,0)
 ;;=R59.0^^18^208^58
 ;;^UTILITY(U,$J,358.3,2809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2809,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Localized
 ;;^UTILITY(U,$J,358.3,2809,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,2809,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,2810,0)
 ;;=R59.9^^18^208^59
 ;;^UTILITY(U,$J,358.3,2810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2810,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Unspec
 ;;^UTILITY(U,$J,358.3,2810,1,4,0)
 ;;=4^R59.9
 ;;^UTILITY(U,$J,358.3,2810,2)
 ;;=^5019531
 ;;^UTILITY(U,$J,358.3,2811,0)
 ;;=L60.9^^18^208^61
 ;;^UTILITY(U,$J,358.3,2811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2811,1,3,0)
 ;;=3^Nail Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,2811,1,4,0)
 ;;=4^L60.9
 ;;^UTILITY(U,$J,358.3,2811,2)
 ;;=^5009240
 ;;^UTILITY(U,$J,358.3,2812,0)
 ;;=L60.3^^18^208^62
 ;;^UTILITY(U,$J,358.3,2812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2812,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,2812,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,2812,2)
 ;;=^5009236
